- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of MK-0616 Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia
This study is testing a new medicine, MK-0616, to see if it can help lower high cholesterol as well as or better than existing treatments. We're looking at how much 'bad' cholesterol (LDL-C) goes down and if the new medicine is safe for people with high cholesterol.
For: HypercholesterolemiaSpain · France - Ongoing, recruitingTherapeutic use (Phase IV)
A randomized, multicenter, open-label trial comparing the effectiveness of Inclisiran to bempedoic acid on LDL cholesterol (LDL-C) lowering in participants with atherosclerotic cardiovascular disease (VICTORION-CHALLENGE)
This study, called VICTORION-CHALLENGE, is comparing two medicines, Inclisiran and Bempedoic acid, to see which one is better at lowering 'bad' cholesterol (LDL-C) in people who have had heart or circulation problems. We want to find out how much they can reduce cholesterol after about five months.
For: HypercholesterolemiaGermany